Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroscience ; 289: 367-80, 2015 Mar 19.
Article in English | MEDLINE | ID: mdl-25592430

ABSTRACT

Our working hypothesis is that brain neurotrophins and brain Na(+),K(+)-ATPase may be strongly associated with the occurrence of depression in animals subjected to chronic unpredictable mild stress (CUMS). Still, we believe that chrysin, a natural and bioactive flavonoid found in honey and some plants, can provide satisfactory effects on antidepressant therapy. Thus, we aimed to evaluate the effect of CUMS on brain-derived neurotropic factor (BDNF) and nerve growth factor (NGF) levels as well as the Na(+),K(+)-ATPase activity in the hippocampus and prefrontal cortex of female mice. We also aimed to examine the effect of a 28-day oral treatment with chrysin (5 or 20mg/kg) in female mice subjected to CUMS, comparing to the effect of fluoxetine. Results showed that CUMS applied for 28days induced a decrease in BDNF and NGF levels as well as in the Na(+),K(+)-ATPase activity. CUMS also promoted a depressive status in the swimming forced test (FST), in the sucrose preference test, and in corticosterone levels. Chrysin (20mg/kg) and fluoxetine also occasioned the up-regulation of BDNF and NGF levels in non-stressed mice and in mice subjected to CUMS. CUMS decreased non-protein thiol (NPSH) levels and increased reactive oxygen species (ROS) levels. In response to these changes, the glutathione reductase (GR), glutathione peroxidase (GPx) and catalase (CAT) activities were increased in mice exposed to CUMS. Chrysin and fluoxetine treatments protected against all these alterations, suggesting the involvement of the antioxidant function in the antidepressant effect of chrysin and fluoxetine. In conclusion, CUMS decreased BDNF and NGF levels as well as the Na(+),K(+)-ATPase activity in mice. Chrysin presented antidepressant effect in mice on behavioral, neurotrophic and biochemistry parameters equivalent to fluoxetine. Furthermore, we suggest that the up-regulation of BDNF and NGF levels is a mechanism possibly involved in the antidepressant effect of chrysin in mice.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Hippocampus/metabolism , Nerve Growth Factor/metabolism , Prefrontal Cortex/metabolism , Sodium-Potassium-Exchanging ATPase/metabolism , Stress, Psychological/metabolism , Animals , Antidepressive Agents/pharmacology , Antioxidants/pharmacology , Catalase/metabolism , Chronic Disease , Corticosterone/metabolism , Depressive Disorder/drug therapy , Depressive Disorder/metabolism , Disease Models, Animal , Female , Flavonoids/pharmacology , Fluoxetine/pharmacology , Glutathione Peroxidase/metabolism , Glutathione Reductase/metabolism , Hippocampus/drug effects , Mice, Inbred C57BL , Prefrontal Cortex/drug effects , Stress, Psychological/drug therapy , Uncertainty , Up-Regulation/drug effects
2.
Neuroscience ; 256: 61-71, 2014 Jan 03.
Article in English | MEDLINE | ID: mdl-24090962

ABSTRACT

Parkinson's disease (PD) is characterized by progressive dopamine (DA) depletion in the striatum. Exercise has been shown to be a promising non-pharmacological approach to reduce the risk of neurodegeneration diseases. This study was designed to investigate the potential neuroprotective effect of swimming training (ST) in a mouse model of PD induced by 6-hydroxydopamine (6-OHDA) in mice. The present study demonstrated that a 4-week ST was effective in attenuating the following impairments resulting from 6-OHDA exposure: (i) depressive-like behavior in the tail suspension test; (ii) increase in the number of falls in the rotarod test; (iii) impairment on long-term memory in the object recognition test; (iv) increase of the reactive species and interleukin 1-beta (IL-1ß) levels; (v) inhibition of the glutathione peroxidase (GPx) activity; (vi) rise of the glutathione reductase (GR) and glutathione S-transferase (GST) activities and vii) decrease of DA, homovanillic acid (HVA) and 3,4-dihydroxyphenylacetic acid (DOPAC) levels. The mechanisms involved in this study are the modulation of GPx, GR and GST activities as well as IL-1ß level in a PD model induced by 6-OHDA, protecting against the decrease of DA, DOPAC and HVA levels in the striatum of mice. These findings reinforce that one of the effects induced by exercise on neurodegenerative disease, such as PD, is due to antioxidant and anti-inflammatory properties. We suggest that exercise attenuates cognitive and motor declines, depression, oxidative stress, and neuroinflammation induced by 6-OHDA supporting the hypothesis that exercise can be used as a non-pharmacological tool to reduce the symptoms of PD.


Subject(s)
Exercise Therapy/methods , Hydroxydopamines/toxicity , Parkinson Disease/etiology , Parkinson Disease/rehabilitation , Swimming/physiology , Animals , Catalase/metabolism , Citrate (si)-Synthase/metabolism , Corpus Striatum/enzymology , Depression/etiology , Disease Models, Animal , Exploratory Behavior/drug effects , Glutathione Peroxidase/metabolism , Hindlimb Suspension , Male , Mice , Mice, Inbred C57BL , Muscle, Skeletal/enzymology , Parkinson Disease/physiopathology , Psychomotor Performance , Recognition, Psychology , Rotarod Performance Test
SELECTION OF CITATIONS
SEARCH DETAIL